Evaluation of the impact of National HIV Testing Day--United States, 2011-2014.
After two decades of campaigns promoting the annual NHTD, it is important to know whether these efforts have resulted in an increase in the number of new HIV diagnoses and whether persons at highest risk for HIV infection are effectively reached. NHTD includes approximately 400 events across the United States, spanning several days. The primary goal is to promote HIV testing, an essential step in the diagnosis of HIV, linkage to antiretroviral therapy, and prevention of new infections (1,2). This goal aligns with the National HIV/AIDS Strategy focused on reducing HIV infections, optimizing health outcomes, and decreasing disparities (3). Among persons disproportionately affected, blacks account for approximately half of all newly identified HIV-positive persons, and gay, bisexual, and other MSM are more severely affected by HIV than any other group (4-6). In 2010, HIV testing during the week of NHTD indicated both an increase in CDC-funded HIV testing events and new HIV diagnoses compared with 2 control weeks (7).
To evaluate whether NHTD campaigns have been successful at increasing the number of persons who know their HIV status, test-level data from the NHM&E data system were extracted and analyzed for the years 2011-2014. Data submitted by 55 grantees in 2011, 59 in 2012, 61 in 2013, and 60 in 2014 from CDC-funded jurisdictions in the United States, Puerto Rico, and the U.S. Virgin Islands were included. Analysis of valid HIV testing event data was conducted. A valid HIV testing event was defined as an event in which either HIV test technology or an HIV test result was reported. A single testing event included one test (i.e., a single rapid test or single conventional test) or more tests (i.e., single rapid test followed by a single conventional test) conducted to determine a person's HIV status. An HIV-positive testing event for a person who was not reported previously as testing positive for HIV was categorized as a newly identified HIV infection. The number of HIV testing events conducted during the month of June was compared with the number of HIV testing events conducted during all remaining months of the year (i.e., January-May and July-December). A chi-square test was used to detect differences between the number of HIV testing events conducted in June and the average number of HIV testing events conducted during the remainder of the year. A p-value <0.05 was considered statistically significant. The differences in the number of testing events and newly identified HIV infections were analyzed by selected demographic characteristics, including age, sex, gender, sexual orientation, race/ethnicity, and risk behaviors. The number of newly identified HIV-positive persons identified each day during the 2 weeks before and after June 27th were compared to determine whether there was an increase on NHTD and to examine testing trends leading up to and after NHTD.
A total of 13,051,035 CDC-funded HIV testing events were conducted during 2011-2014, including 3,299,690 (2011); 3,287,024 (2012); 3,343,633 (2013); and 3,120,688 (2014). The numbers of new HIV-positive test results were 17,216 (0.52%) for 2011; 16,976 (0.52%) for 2012; 17,426 (0.52%) for 2013; and 16,530 (0.53%) for 2014. The number of testing events peaked in June compared with the mean during January-May and July-December for each year during 2011-2014, and the mean number of newly identified HIV-positive persons increased significantly during June (p<0.001) compared with January-May and July-December (Figure 1). When the number of new HIV infections diagnosed each day during the 2 weeks before and after NHTD was compared with new HIV infections diagnosed on June 27, the annual national testing event identified the largest number of new HIV infections compared with any of the other days (Figure 2). New HIV infections identified on NHTD, compared with those identified on the next highest day, increased 25% in 2011, 40% in 2012, 20% in 2013, and 17% in 2014 (Figure 2). The increase in total HIV testing events and the number of newly identified HIV infections was significant for persons aged [greater than or equal to] 20 years; for all sex and gender groups (male, female, and transgender); MSM and heterosexuals; and white, black and Hispanic/Latino racial/ethnic groups (Table). MSM identified as white, black, or Hispanic/Latino experienced a significant increase in testing events and newly identified HIV-positive persons in June (Table).
[FIGURE 1 OMITTED]
National HIV Testing Day (NHTD) effectively targets groups disproportionately affected by HIV. During 2011-2014, there was a significant increase in total testing events as well as newly identified HIV-positive persons in June compared with other months, with a peak in new HIV diagnoses on NHTD. This increase was seen across gender groups, persons aged [greater than or equal to] 20 years, and all major racial/ethnic groups. A higher number of testing events and newly identified positive HIV diagnoses occurred among MSM, irrespective of race/ethnicity, and among transgender persons in June compared with the mean during all other months.
[FIGURE 2 OMITTED]
Testing is the first link in the chain to provide treatment and disrupt transmission, because persons who are aware that they have HIV infection are less likely to transmit HIV (8,9). Promoting NHTD is an effective strategy to increase HIV testing and thereby, the number of persons who are aware of their HIV status. Because blacks are less likely to have their infection diagnosed and have higher HIV-related mortality rates than other racial/ethnic groups in the United States, it is important to design interventions that specifically target HIV testing for this population (4). NHTD campaigns are usually scheduled by state and local health departments, pharmacies, and HIV community-based organizations in June, leading up to NHTD. These findings indicate persons at highest risk for HIV by age, sex, racial/ethnic group, and target population are effectively reached by mass testing campaigns.
The findings in this report are subject to at least three limitations. First, these analyses included only CDC-funded HIV tests. Therefore, HIV tests supported by other funding sources were not included. Second, the month of June also includes a substantial number of community-based testing events associated with gay pride celebrations in large U.S. cities. It is difficult to know how this might have contributed to an increase in HIV testing and new diagnoses observed during this month. However, a peak in HIV testing and new HIV diagnosis was observed on NHTD compared with all other days. Finally, this study shows increased HIV testing with NHTD; however, receipt of individual test results was not examined. Hence, the magnitude of awareness of individual HIV status cannot be determined from the study.
As a public health strategy consistent with the National HIV/ AIDS Strategy, NHTD identifies a number of new HIV infections in populations disproportionately affected by HIV and might increase awareness of HIV status among HIV-infected persons. NHTD might be used strategically in future efforts to increase testing in areas with the highest incidence of HIV. These findings suggest that community-level approaches to advocate early detection and treatment of HIV infection might use mass testing events such as those promoted for NHTD in areas where HIV is most prevalent.
What is already known about this topic?
For approximately 2 decades, June 27th has been designated as National human immunodeficiency virus (HIV) Testing Day (NHTD) to promote HIV testing and increase awareness of the importance of getting tested for HIV.
What is added by this report?
During 2011-2014, there were more CDC-funded HIV testing events and newly identified HIV infections during the month of June compared with the mean for all other months, with significant differences for those most affected by HIV, such as African American (black) men and men who have sex with men (MSM). Compared with the 2 weeks before and after NHTD, the highest number of newly identified HIV positive persons occurred on June 27th each year.
What are the implications for public health practice?
NHTD is an important event to help achieve the National HIV/ AIDS Strategy to increase the percentage of persons living with HIV who are aware of their status. NHTD is effective in identifying new HIV-positive diagnoses and identifies persons at highest risk for HIV infection, including black men and MSM.
(1.) CDC. National HIV testing day and new testing recommendations. MMWR Morb Mortal Wkly Rep 2014; 63:537.
(2.) CDC. National HIV testing day--June 27, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:441.
(3.) Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: Office of National AIDS Policy; 2010. http://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas.pdf
(4.) Siddiqi AE, Hu X, Hall HI. Mortality among blacks or African Americans with HIV infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2015; 64:81-6.
(5.) CDC. Estimated HIV incidence among adults and adolescents in the United States, 2007-2010. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf
(6.) Seth P, Walker T, Hollis N, Figueroa A, Belcher L. HIV testing and service delivery among blacks or African Americans--61 health department jurisdictions, United States, 2013. MMWR Morb Mortal Wkly Rep 2015; 64:87-90.
(7.) Van Handel M, Mulatu MS. Effectiveness of the US national HIV testing day campaigns in promoting HIV testing: evidence from CDC-funded HIV testing sites, 2010. Public Health Rep 2014; 129:446-54.
(8.) Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-50. http://dx.doi.org/10.1097/01. aids.0000233579.79714.8d
(9.) Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012; 26:893-6. http://dx.doi.org/10.1097/QAD.0b013e328351f73f
Shirley Lee Lecher, MD ; NaTasha Hollis, PhD ; Christopher Lehmann, MD ; Karen W Hoover, MD ; Avatar Jones ; Lisa Belcher, PhD 
 Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.
Corresponding author: NaTasha Hollis, firstname.lastname@example.org, 404-718-8636.
TABLE. Number of HIV testing events and HIV positivity for selected characteristics conducted by health departments providing test-level data in the United States, Puerto Rico and the U.S. Virgin Islands, 2011-2014 Total HIV testing events, 2011-2014 Characteristic June 11 mos p-value (total) (mean) * Age group (yrs) <13 2,225 2,058 0.011 13-19 100,297 96,689 <0.001 20-29 473,562 439,494 <0.001 30-39 267,331 239,610 <0.001 40-49 173,300 150,241 <0.001 [greater than or equal to] 50 173,506 141,857 <0.001 Invalid/Missing ([dagger]) 7,498 7,626 -- Sex Male 583,786 525,661 <0.001 Female 604,552 543,579 <0.001 Transgender 4,343 3,284 <0.001 Invalid/Missing ([section]) 5,038 5,050 -- Race/Ethnicity White 318,557 292,036 <0.001 Black 538,850 476,566 <0.001 Hispanic 257,342 229,503 <0.001 Other ([paragraph]) 40,428 36,468 <0.001 Invalid/Missing ** 42,542 43,001 -- Target population ([dagger][dagger]) Male-to-male sexual contact 2,782 2,564 0.003 and injection drug use Male-to-male sexual contact 97,890 79,991 <0.001 Transgender and injection 187 164 0.214 drug use Transgender 4,156 3,121 <0.001 Injection drug use 28,604 25,879 <0.001 Heterosexual 537,641 485,172 <0.001 Male-to-male sexual contact by race/ethnicity White, non-Hispanic 43,512 35,985 <0.001 Black, non-Hispanic 24,540 19,998 <0.001 Hispanic 23,617 19,065 <0.001 Total 1,197,719 1,077,574 <0.001 Newly identified HIV infections, 2011-2014 Characteristic June 11 mos p-value (total) (mean) * Age group (yrs) <13 7 7 0.942 13-19 212 193 0.343 20-29 2,469 2,239 0.001 30-39 1,486 1,341 0.006 40-49 1,265 1,012 <0.001 [greater than or equal to] 50 982 766 <0.001 Invalid/Missing ([dagger]) 34 51 -- Sex Male 5,141 4,454 <0.001 Female 1,177 1,063 0.016 Transgender 103 69 0.010 Invalid/Missing ([section]) 34 23 -- Race/Ethnicity White 1,309 1,159 0.003 Black 3,404 2,964 <0.001 Hispanic 1,361 1,167 <0.001 Other ([paragraph]) 201 170 0.105 Invalid/Missing ** 180 148 -- Target population ([dagger][dagger]) Male-to-male sexual contact 112 97 0.287 and injection drug use Male-to-male sexual contact 2,720 2,420 <0.001 Transgender and injection 6 5 0.676 drug use Transgender 97 65 0.011 Injection drug use 133 122 0.498 Heterosexual 1,767 1,551 <0.001 Male-to-male sexual contact by race/ethnicity White, non-Hispanic 803 662 <0.001 Black, non-Hispanic 1,196 1,102 0.049 Hispanic 681 605 0.034 Total 6,455 5,608 <0.001 Abbreviation: HIV = human immunodeficiency virus. * The sum of the average during January-May and July-December over 3 years (2011-2014). ([dagger]) Includes invalid and/or missing values that are needed to determine age. ([section]) Includes other specified, declined/not asked, or invalid/missing. ([paragraph]) Includes multirace, Asian, American Indian, Alaskan Native, Native Hawaiian, or Pacific Islander. ** Includes declined, don't know/not asked, invalid/missing. ([dagger][dagger]) Data to identify target populations are required for all testing events conducted in non-health care settings and only HIV-positive testing events in health care settings.
|Printer friendly Cite/link Email Feedback|
|Author:||Lecher, Shirley Lee; Hollis, NaTasha; Lehmann, Christopher; Hoover, Karen W.; Jones, Avatar; Belcher|
|Publication:||Morbidity and Mortality Weekly Report|
|Date:||Jun 24, 2016|
|Previous Article:||National HIV Testing Day--June 27, 2016.|
|Next Article:||Health care use and HIV testing of males aged 15-39 years in physicians' offices--United States, 2009-2012.|